Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-13T01:35:04.706Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of Bipolar Mania

Published online by Cambridge University Press:  07 November 2014

Robert M. Post ,
Philip G. Janicak ,
Melissa P. DelBello  and
David L. Ginsberg
Robert M. Post
Affiliation:
Dr. Post is head of the Bipolar Collaborative Network in Chevy Chase, Maryland.
Get access Rights & Permissions [Opens in a new window]

Abstract

While severity of manic episodes can be successfully reduced, repeated recurrences are common with ~40% of patients meeting criteria for rapid cycling after aggressive treatment. Manic episodes present much earlier in children of bipolars and due to unique presentation physicians often mistakenly diagnose such children with attention-deficit/hyperactivity disorder. Differential symptoms include suicidal thoughts, grandiosity, hallucinations, and depressive withdrawal. Such children may require the usual combination treatment with a mood stabilizer and an antipsychotic, with the addition of a stimulant as well. Treatment of adults and children often includes second-generation antipsychotics, which have increasingly shown efficacy both as monotherapy and adjunctive treatments of acute mania. Most recently, some anticonvulsants have demonstrated acute antimanic properties as well and more studies of their role in bipolar disorder are underway.

Type
Research Article
Information
CNS Spectrums , Volume 9 , Issue S1 , 2004 , pp. 1 - 7
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Post, RM, Leverich, GS, Nolen, WA, et al.A reevaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Bipolar Treatment Network. Bipolar Disord. 2003. In press.Google Scholar
2.Suppes, T, Leverich, GS, Keck, PE, et al.The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord. 2001;67:45–59.CrossRefGoogle ScholarPubMed
3.Kupka, R. Rapid cycling. Discrimination factors in rapid and non-rapid cycling bipolar disorder. 2003. University of Utrecht dissertation.CrossRefGoogle Scholar
4.Lange, KJ, McInnis, MG. Studies of anticipation in bipolar affective disorder. CNS Spectr. 2002;7:196–202.CrossRefGoogle ScholarPubMed
5.Geller, B, Craney, JL, Bolhofner, K, Nickelsburg, MJ, Williams, M, Zimerman, B. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry. 2002;159:927–933.CrossRefGoogle ScholarPubMed
6.Findling, RL, Kowatch, RA, Post, RM. Pediatric Bipolar Disorder. London, England: Martin Dunitz Ltd.; 2002.Google Scholar
7.Chuang, DM, Chen, RW, Chalecka-Franaszek, E, et al.Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord. 2002;4:129–136.CrossRefGoogle ScholarPubMed
8.Manji, HK, Moore, GJ, Chen, G. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers. Br J Psychiatry. 2001;178(suppl):S107–S119.CrossRefGoogle ScholarPubMed
9.Moore, GJ, Bebchuk, JM, Hasanat, K, et al.Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects? Biol Psychiatry. 2000;48:1–8.CrossRefGoogle ScholarPubMed
10.Moore, GJ, Bebchuk, JM, Wilds, IB, Chen, G, Manji, HK. Lithium-induced increase in human brain grey matter. Lancet. 2000;356:1241–1242.CrossRefGoogle ScholarPubMed